Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Melina SantosCamelia ProtopopescuElizabeth Delarocque-AstagneauMarc BourlièreVentzislava Petrov-SanchezVincent Di BeoDominique LarreyMaël BaudoinCéline DorivalMorgane BureauHélène FontaineFabrice CarratFabienne MarcellinStanislas PolPatrizia Maria Carrierinull nullPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
As late presentation severely affects HCV cascade of care, our findings bring important new evidence about the need to promptly identify and target people with diabetes and/or past or current hazardous alcohol use for HCV screening and treatment within the wider context of the WHO goal to eliminate HCV by 2030.